Role of the CYP2D6, EPHX1, MPO, and NQO1 genes in the susceptibility to acute lymphoblastic leukemia in Brazilian children
- PMID: 19593802
- DOI: 10.1002/em.20510
Role of the CYP2D6, EPHX1, MPO, and NQO1 genes in the susceptibility to acute lymphoblastic leukemia in Brazilian children
Abstract
Polymorphic variations of several genes associated with dietary effects and exposure to environmental carcinogens may influence susceptibility to leukemia development. The objective of the present study was to evaluate the effect of the polymorphisms of debrisoquine hydroxylase (CYP2D6), epoxide hydrolase (EPHX1), myeloperoxidase (MPO), and quinone-oxoreductase (NQO1), which have been implicated in xenobiotic metabolism, on the risk of childhood acute lymphoblastic leukemia (ALL). We evaluated the frequency of polymorphisms in the CYP2D6 (*3 and *4), EPHX1 (*2 and *3), MPO (*2), and NQO1 (*2) genes in 206 patients with childhood ALL and in 364 healthy individuals matched for age and gender from a Brazilian population separated by ethnicity (European ancestry and African ancestry), using the PCR-RFLP method. The CYP2D6 polymorphism variants were associated with an increased risk of ALL. The EPHX1, NQO1, and MPO variant genotypes were significantly associated with a reduced risk of childhood ALL. A significantly stronger protective effect is observed when the EPHX1, NQO1, and MPO variant genotypes are combined suggesting that, CYP2D6 polymorphisms may play a role in the susceptibility to pediatric ALL, whereas the EPHX1, NQO1, and MPO polymorphisms might have a protective function against leukemogenesis.
(c) 2009 Wiley-Liss, Inc.
Similar articles
-
Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia.Leuk Res. 2009 Jul;33(7):898-901. doi: 10.1016/j.leukres.2008.12.006. Epub 2009 Jan 21. Leuk Res. 2009. PMID: 19162321
-
Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes in a Brazilian population.Biomarkers. 2009 Mar;14(2):111-7. doi: 10.1080/13547500902767294. Biomarkers. 2009. PMID: 19330589
-
Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia.Arch Toxicol. 2012 Mar;86(3):431-9. doi: 10.1007/s00204-011-0760-8. Epub 2011 Oct 9. Arch Toxicol. 2012. PMID: 21983886
-
NQO1, MPO, and the risk of lung cancer: a HuGE review.Genet Med. 2005 Sep;7(7):463-78. doi: 10.1097/01.gim.0000177530.55043.c1. Genet Med. 2005. PMID: 16170238 Review.
-
[Genetic determinants of childhood leukemia].Bull Cancer. 2006 Sep;93(9):857-65. Bull Cancer. 2006. PMID: 16980228 Review. French.
Cited by
-
Metabolic Polymorphisms and Clinical Findings Related to Benzene Poisoning Detected in Exposed Brazilian Gas-Station Workers.Int J Environ Res Public Health. 2015 Jul 21;12(7):8434-47. doi: 10.3390/ijerph120708434. Int J Environ Res Public Health. 2015. PMID: 26197327 Free PMC article.
-
Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study.BMC Cancer. 2013 May 7;13:228. doi: 10.1186/1471-2407-13-228. BMC Cancer. 2013. PMID: 23651475 Free PMC article.
-
CYP2D6 rs35742686 and rs3892097 Gene Polymorphisms and Childhood Acute Lymphoblastic Leukemia: Relation to Disease Susceptibility in Kashmiri Children.J Pediatr Genet. 2021 Feb 19;11(3):213-220. doi: 10.1055/s-0041-1723975. eCollection 2022 Sep. J Pediatr Genet. 2021. PMID: 35990039 Free PMC article.
-
Genetic susceptibility in childhood acute leukaemias: a systematic review.Ecancermedicalscience. 2015 May 14;9:539. doi: 10.3332/ecancer.2015.539. eCollection 2015. Ecancermedicalscience. 2015. PMID: 26045716 Free PMC article. Review.
-
Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies.World J Surg Oncol. 2017 Aug 2;15(1):144. doi: 10.1186/s12957-017-1183-7. World J Surg Oncol. 2017. PMID: 28764808 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous